Showing results (51-60 of 113) with videos related to
Sort By:
Pageof 12
Cancer Chemotherapy and Pharmacology|January 1, 1990
Tumor-tissue and plasma concentrations of platinum during chemotherapy of non-small-cell lung cancer patientsJ L Pujol, D Cupissol, C Gestin-Boyer, et al.Cancer Research|January 1, 1993
Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancerJ L Pujol, J Grenier, J P Daurès, et al.The American Review of Respiratory Disease|May 1, 1992
Chest tumor response measurement during lung cancer chemotherapy. Comparison between computed tomography and standard roentgenographyJ L Pujol, P Demoly, J P Daurès, et al.Journal of the National Cancer Institute|November 17, 1993
Immune response induced in small-cell lung cancer by maintenance therapy with interferon gammaJ L Pujol, D J Gibney, J Q Su, et al.Revue Des Maladies Respiratoires|November 7, 1998
[Neuron-specific enolase (NSE) in the surveillance of small cell cancers. An evaluation of the prognostic information using Markov's model]J L Pujol, J M Boher, J Grenier, et al.Lung Cancer (Amsterdam, Netherlands)|October 1, 1993
Immunohistochemical study of P-glycoprotein distribution in lung cancerJ L Pujol, J Simony, V Gautier, et al.Nuclear Medicine and Biology|April 1, 1994
Cyfra 21-1, a new marker of lung cancerJ Grenier, J L Pujol, F Guilleux, et al.Revue Des Maladies Respiratoires|January 1, 1992
[Evolution of bronchial hyperreactivity during post-exercise asthma]J L Pujol, A Varray, A M Savy-Pacaud, et al.American Journal of Respiratory and Critical Care Medicine|September 1, 1996
Cytokeratins as serum markers in lung cancer: a comparison of CYFRA 21-1 and TPSJ L Pujol, J Grenier, E Parrat, et al.Respiratory Medicine|May 1, 1995
Fos immunoreactivity assessment on human normal and pathological bronchial biopsiesP Demoly, P Chanez, J L Pujol, et al.Pageof 12